RFPT05--New Ways to Combat CF Pathogens

Chair(s)

• 

  Katrine Whiteson, PhD

  University of California Irvine
• OM

  Oliver McElvaney, MD, PhD

Presentations:

• 1:30 PM - 2:20 PM PDT

  The use of a novel MycoMEIA^® Aspergillus Assay for Aspergillus detection in the urine of people with cystic fibrosis
  

  Speaker: Gina Hong, MD, MHS – University of Pennsylvania Perelman School of Medicine
• 1:30 PM - 2:20 PM PDT

  Impact of sphingosine as an antimicrobial against CF pathogens and synergy with antibiotics
  

  Speaker: Matthew J. Wargo, n/a – University of Vermont Larner College of Medicine
• 1:30 PM - 2:20 PM PDT

  Sputum Volatiles Differentiate M. avium Complex and M. abscessus Species Infections in People with Cystic Fibrosis
  

  Speaker: Antao Gao, n/a – University of British Columbia
• 1:30 PM - 2:20 PM PDT

  Modulation of interbacterial interactions by Pseudomonas aeruginosa quorum sensing
  

  Speaker: Andrew Frando, PhD – University of Washington
• 1:30 PM - 2:20 PM PDT

  An oncometabolic pathway that drives cystic fibrosis lung disease
  

  Speaker: Gaurav Kumar Lohia, n/a – Columbia University Irving Medical Centre
• 1:30 PM - 2:20 PM PDT

  Broad Spectrum Synergy Between Fatty Acids, Bacteriophages, and Antibiotics
  

  Speaker: Sage J. B. Dunham, n/a – UC Irvine
• 1:30 PM - 2:20 PM PDT

  Targeting Mycobacterium abscessus: Dual Mechanisms and Enhanced Killing by Optimized β-Lactam/β-Lactamase Inhibitor Combinations
  

  Speaker: Eunjeong Shin, n/a – Case Western Reserve University
• 1:30 PM - 2:20 PM PDT

  Characterization of bacteriophages that lyse diverse cystic fibrosis Stenotrophomonas maltophilia complex isolates
  

  Speaker: Cristian V. Crisan, n/a